Claim being checked · Version 1 · Reviewed
“Small studies tested Selank in people with anxiety-related conditions.”
Written and source-checked by Anthony Treviso, founder of The Peptide Field.
No dosing advice. This guide explains research. It was not independently medically reviewed, and it does not diagnose, prescribe, or recommend treatment.
Supported with scope. The reviewed evidence supports this exact statement only in the situation described below.
Answer scope
This verdict checks the exact claim in the heading. It is not a universal grade for Selank.
01 · Answer
Supported with scope
Yes. One randomized report compared Selank with medazepam in 62 people. Another randomized report included 70 people. Forty received Selank with phenazepam, and 30 received phenazepam alone. These small studies do not prove a broad benefit.
- What kind of evidence this is
- Randomized human outcomes. This answer uses a study that assigned people to groups by chance and measured a health outcome.
- What this answer covers
- Small studies in people with specific anxiety-related conditions. The reports do not establish a result for every anxiety condition or population. This answer covers only the named molecule and finished product. It also covers the product form and how people used it. The study limits include who took part, what was used for comparison, what changed, and how long the study lasted.
- Question type
- Clinical outcomes. What a study measured about people's health, symptoms, or ability to function.
02 · Sources
Read the sources behind this answer
Supports the scoped claim02Phenazepam alone compared with phenazepam plus Selank in 70 peoplePubMed · Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova · Randomized trial · 2015
Supports the scoped claim
- Editorial review
- Internal editorial review recorded
- Source review
- Anthony Treviso · Founder and responsible editor
- Medical review status
- Not independently medically reviewed. Editorial source review does not replace medical review.